Madam .... From MSB's perspective its about receiving the $$ and also partnering with a Pharma that is passionate about MPC's and also having capable distribution and sales team.
MNK is a $4.8bn mkt cap company with $3m bn sales turnover.
As you were not around at the time, let me help you understand that CEPH (Dec 2010) was a $3.5bn mkt cap company with a $2.5bn turnover at the time. History will tell you CEPH paid $350M to Mesoblast in partnering Revacsor + cord blood ( plus $1.7bn on agreed milest0nes).
Here is an article at the time the deal occurred. Please read it for your own benefit.
http://www.genengnews.com/gen-news-...ialize-mesoblast-stem-cell-therapies/81244348
So given the similarities with CEPH ( a passionate and hungry Global Pharma) , in my view MNK would be an accomplished and adept partner with the financial capacity to deliver for MSB ....
.....are we about to experience Dec 2010 all over again ?
GLTAH
- Forums
- ASX - By Stock
- MSB
- My thoughts on what matters to MNK
My thoughts on what matters to MNK, page-13
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.080(7.24%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $9.801M | 8.501M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 42609 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 38521 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 92701 | 1.190 |
18 | 79117 | 1.185 |
17 | 303324 | 1.180 |
10 | 84694 | 1.175 |
4 | 30632 | 1.170 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 671349 | 48 |
1.205 | 86803 | 10 |
1.210 | 214681 | 16 |
1.215 | 129338 | 6 |
1.220 | 6319 | 3 |
Last trade - 14.14pm 12/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |